Bioprocessing of Viral Vaccines (eBook, ePUB)
Redaktion: Kamen, Amine; Cervera, Laura
48,95 €
48,95 €
inkl. MwSt.
Sofort per Download lieferbar
24 °P sammeln
48,95 €
Als Download kaufen
48,95 €
inkl. MwSt.
Sofort per Download lieferbar
24 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
48,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
24 °P sammeln
Bioprocessing of Viral Vaccines (eBook, ePUB)
Redaktion: Kamen, Amine; Cervera, Laura
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book focuses on cell culture-produced viral vaccines to meet the needs of the rapidly expanding research and development in academia and industry in the field. This book introduces the basic principles of vaccination and the manufacturing of viral vaccines.
- Geräte: eReader
- ohne Kopierschutz
- eBook Hilfe
- Größe: 6.33MB
Andere Kunden interessierten sich auch für
- Bioprocessing of Viral Vaccines (eBook, PDF)48,95 €
- Sudip PoddarError-Tolerant Biochemical Sample Preparation with Microfluidic Lab-on-Chip (eBook, ePUB)48,95 €
- Stimuli-Responsive Nanomedicine (eBook, ePUB)121,95 €
- Arthur B. RitterBiomedical Engineering Principles (eBook, ePUB)57,95 €
- Computational Intelligence in Medical Decision Making and Diagnosis (eBook, ePUB)49,95 €
- Transport Phenomena in Biomedical Engineering (eBook, ePUB)141,95 €
- Ryszard UklejewskiPrototype of a Biomimetic Multi-Spiked Connecting Scaffold for a New Generation of Resurfacing Endoprostheses (eBook, ePUB)0,99 €
-
-
-
This book focuses on cell culture-produced viral vaccines to meet the needs of the rapidly expanding research and development in academia and industry in the field. This book introduces the basic principles of vaccination and the manufacturing of viral vaccines.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 328
- Erscheinungstermin: 6. September 2022
- Englisch
- ISBN-13: 9781000643053
- Artikelnr.: 64348016
- Verlag: Taylor & Francis
- Seitenzahl: 328
- Erscheinungstermin: 6. September 2022
- Englisch
- ISBN-13: 9781000643053
- Artikelnr.: 64348016
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Amine Kamen is a professor of bioengineering at McGill University, and Canada Research Chair in bioprocessing of viral vaccines. He is a researcher emeritus of the National Research Council of Canada (NRC) where he was employed until early 2014, as head of the Process Development section of the Human Health Therapeutics Portfolio. At NRC, he established one of North America's largest and most advanced governmental centers for animal cell culture addressing process development and scale-up of biologics. Also, he developed with his team and licensed to industry multiple technology platforms for efficient manufacturing of recombinant proteins and viral vectors and vaccines and led technology transfer to manufacturing sites for clinical evaluation and commercialization. His current research activities focus on uncovering mechanisms associated with cell production of viral vectors and viral vaccines, cell and metabolic engineering, process control and monitoring, and process analytical technologies of high-yield productions of viral vectors for gene delivery and vaccination. He has published over 170 papers in refereed international journals and acts as a consultant for several national and international private and public organizations. Laura Cervera is a Chemical Engineer from Universitat Autònoma de Barcelona (Barcelona, Spain). After graduating she did her PhD in Biotechnology on the topic "Strategies for improving production levels of HIV-1 VLPs by transient transfection of HEK 293 suspension cultures". Then she moved to McGillUniversity (Montreal, Canada) to pursue her research on VLP production, this time using Insect cells as a platform. She came back to Barcelona to join a project on AAV production for gene therapy applications using HEK 293 cells.
1. Bioprocessing of viral vaccines-Introduction. 2. Introduction to
Virology. 3. Principles of immunology. 4. Cell lines for vaccine
production. 5. Upstream Processing for Viral Vaccines - General Aspects. 6.
Upstream Processing for Viral Vaccines - Process Intensification. 7.
Downstream Processing of Viral Vaccines. 8. Analytical, QbD and PAT Applied
to Viral Production Processes. 9. Manufacturing of seasonal and pandemic
influenza vaccines - a case study. 10. Recombinant vaccines: Gag-based
VLPs. 11. Vectored Vaccines. 12. Design and Production of Vaccines Against
COVID-19 using Established Vaccine Platforms.
Virology. 3. Principles of immunology. 4. Cell lines for vaccine
production. 5. Upstream Processing for Viral Vaccines - General Aspects. 6.
Upstream Processing for Viral Vaccines - Process Intensification. 7.
Downstream Processing of Viral Vaccines. 8. Analytical, QbD and PAT Applied
to Viral Production Processes. 9. Manufacturing of seasonal and pandemic
influenza vaccines - a case study. 10. Recombinant vaccines: Gag-based
VLPs. 11. Vectored Vaccines. 12. Design and Production of Vaccines Against
COVID-19 using Established Vaccine Platforms.
1. Bioprocessing of viral vaccines-Introduction. 2. Introduction to
Virology. 3. Principles of immunology. 4. Cell lines for vaccine
production. 5. Upstream Processing for Viral Vaccines - General Aspects. 6.
Upstream Processing for Viral Vaccines - Process Intensification. 7.
Downstream Processing of Viral Vaccines. 8. Analytical, QbD and PAT Applied
to Viral Production Processes. 9. Manufacturing of seasonal and pandemic
influenza vaccines - a case study. 10. Recombinant vaccines: Gag-based
VLPs. 11. Vectored Vaccines. 12. Design and Production of Vaccines Against
COVID-19 using Established Vaccine Platforms.
Virology. 3. Principles of immunology. 4. Cell lines for vaccine
production. 5. Upstream Processing for Viral Vaccines - General Aspects. 6.
Upstream Processing for Viral Vaccines - Process Intensification. 7.
Downstream Processing of Viral Vaccines. 8. Analytical, QbD and PAT Applied
to Viral Production Processes. 9. Manufacturing of seasonal and pandemic
influenza vaccines - a case study. 10. Recombinant vaccines: Gag-based
VLPs. 11. Vectored Vaccines. 12. Design and Production of Vaccines Against
COVID-19 using Established Vaccine Platforms.